Knocking out IL‐6 by vaccination

Inappropriate expression of IL‐6 plays a role in various inflammatory conditions, degenerative diseases, and cancers. Several model systems have been developed that can specifically block IL‐6‐receptor interactions. Here we present a simple and highly effective approach based on vaccination with a p...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2004-01, Vol.34 (1), p.291-300
Main Authors: Galle, Pia, Hougs, Lotte, Barington, Torben, Svenson, Morten, Svejgaard, Arne, Thomsen, Allan R., Bendtzen, Klaus, Hansen, Morten B.
Format: Article
Language:English
Subjects:
Amino Acid Sequence
Animals
Antibodies - immunology
Autoimmunity
Female
Humans
Inflammation
Interleukin-6 - analogs & derivatives
Interleukin-6 - immunology
Interleukin‐6
Mice
Molecular Sequence Data
Protein Structure, Tertiary
Tolerance
Vaccination
Vaccines - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3768-3f0b5beea726eb210119f360572d6e190eeff15b90a70b87879b5ee7b62317803
cites cdi_FETCH-LOGICAL-c3768-3f0b5beea726eb210119f360572d6e190eeff15b90a70b87879b5ee7b62317803
container_end_page 300
container_issue 1
container_start_page 291
container_title European journal of immunology
container_volume 34
creator Galle, Pia
Hougs, Lotte
Barington, Torben
Svenson, Morten
Svejgaard, Arne
Thomsen, Allan R.
Bendtzen, Klaus
Hansen, Morten B.
description Inappropriate expression of IL‐6 plays a role in various inflammatory conditions, degenerative diseases, and cancers. Several model systems have been developed that can specifically block IL‐6‐receptor interactions. Here we present a simple and highly effective approach based on vaccination with a pool of specifically mutated IL‐6 analogues to induce a neutralizing IL‐6 antibody responsein mice. Judged by the ability of the analogues to bind to heterologous anti‐IL‐6 antibodies and cellular IL‐6 receptors the IL‐6 analogues seemed to have a three‐dimensional structure comparable to that of wild‐type IL‐6. Injection of them broke self‐tolerance and induced an immune response to IL‐6, presumably because of the amino acid differences between the analogues and wild‐type IL‐6. This resulted in a long‐lasting anti‐IL‐6 antibody‐mediated IL‐6 deficiency that blocked experimentally induced IL‐6‐mediated pathology.
doi_str_mv 10.1002/eji.200324338
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80169194</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80169194</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3768-3f0b5beea726eb210119f360572d6e190eeff15b90a70b87879b5ee7b62317803</originalsourceid><addsrcrecordid>eNp90L1OwzAUhmELgWgpjKwoYmBLOceO_0ZUFShUYoHZitMTlJImJW6ounEJXCNXQlArujF9y6NveBk7RxgiAL-meTHkAIInQpgD1kfJMU4wwUPWB8Ak5tZAj52EMAcAq6Q9Zj1MrEaQss8uH6s6eyuq16huV9Fk-v35pSK_iT7SLCuqdFXU1Sk7ytMy0NluB-zldvw8uo-nT3eT0c00zoRWJhY5eOmJUs0VeY6AaHOhQGo-U4QWiPIcpbeQavBGG229JNJecYHagBiwq-3vsqnfWwortyhCRmWZVlS3wRlAZdEmHYy3MGvqEBrK3bIpFmmzcQjuN4rrori_KJ2_2B23fkGzvd5V6IDegnVR0ub_Nzd-mOyvfwAK0Gsl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80169194</pqid></control><display><type>article</type><title>Knocking out IL‐6 by vaccination</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Galle, Pia ; Hougs, Lotte ; Barington, Torben ; Svenson, Morten ; Svejgaard, Arne ; Thomsen, Allan R. ; Bendtzen, Klaus ; Hansen, Morten B.</creator><creatorcontrib>Galle, Pia ; Hougs, Lotte ; Barington, Torben ; Svenson, Morten ; Svejgaard, Arne ; Thomsen, Allan R. ; Bendtzen, Klaus ; Hansen, Morten B.</creatorcontrib><description>Inappropriate expression of IL‐6 plays a role in various inflammatory conditions, degenerative diseases, and cancers. Several model systems have been developed that can specifically block IL‐6‐receptor interactions. Here we present a simple and highly effective approach based on vaccination with a pool of specifically mutated IL‐6 analogues to induce a neutralizing IL‐6 antibody responsein mice. Judged by the ability of the analogues to bind to heterologous anti‐IL‐6 antibodies and cellular IL‐6 receptors the IL‐6 analogues seemed to have a three‐dimensional structure comparable to that of wild‐type IL‐6. Injection of them broke self‐tolerance and induced an immune response to IL‐6, presumably because of the amino acid differences between the analogues and wild‐type IL‐6. This resulted in a long‐lasting anti‐IL‐6 antibody‐mediated IL‐6 deficiency that blocked experimentally induced IL‐6‐mediated pathology.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.200324338</identifier><identifier>PMID: 14971055</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies - immunology ; Autoimmunity ; Female ; Humans ; Inflammation ; Interleukin-6 - analogs &amp; derivatives ; Interleukin-6 - immunology ; Interleukin‐6 ; Mice ; Molecular Sequence Data ; Protein Structure, Tertiary ; Tolerance ; Vaccination ; Vaccines - immunology</subject><ispartof>European journal of immunology, 2004-01, Vol.34 (1), p.291-300</ispartof><rights>Copyright © 2004 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3768-3f0b5beea726eb210119f360572d6e190eeff15b90a70b87879b5ee7b62317803</citedby><cites>FETCH-LOGICAL-c3768-3f0b5beea726eb210119f360572d6e190eeff15b90a70b87879b5ee7b62317803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14971055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Galle, Pia</creatorcontrib><creatorcontrib>Hougs, Lotte</creatorcontrib><creatorcontrib>Barington, Torben</creatorcontrib><creatorcontrib>Svenson, Morten</creatorcontrib><creatorcontrib>Svejgaard, Arne</creatorcontrib><creatorcontrib>Thomsen, Allan R.</creatorcontrib><creatorcontrib>Bendtzen, Klaus</creatorcontrib><creatorcontrib>Hansen, Morten B.</creatorcontrib><title>Knocking out IL‐6 by vaccination</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>Inappropriate expression of IL‐6 plays a role in various inflammatory conditions, degenerative diseases, and cancers. Several model systems have been developed that can specifically block IL‐6‐receptor interactions. Here we present a simple and highly effective approach based on vaccination with a pool of specifically mutated IL‐6 analogues to induce a neutralizing IL‐6 antibody responsein mice. Judged by the ability of the analogues to bind to heterologous anti‐IL‐6 antibodies and cellular IL‐6 receptors the IL‐6 analogues seemed to have a three‐dimensional structure comparable to that of wild‐type IL‐6. Injection of them broke self‐tolerance and induced an immune response to IL‐6, presumably because of the amino acid differences between the analogues and wild‐type IL‐6. This resulted in a long‐lasting anti‐IL‐6 antibody‐mediated IL‐6 deficiency that blocked experimentally induced IL‐6‐mediated pathology.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies - immunology</subject><subject>Autoimmunity</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Interleukin-6 - analogs &amp; derivatives</subject><subject>Interleukin-6 - immunology</subject><subject>Interleukin‐6</subject><subject>Mice</subject><subject>Molecular Sequence Data</subject><subject>Protein Structure, Tertiary</subject><subject>Tolerance</subject><subject>Vaccination</subject><subject>Vaccines - immunology</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp90L1OwzAUhmELgWgpjKwoYmBLOceO_0ZUFShUYoHZitMTlJImJW6ounEJXCNXQlArujF9y6NveBk7RxgiAL-meTHkAIInQpgD1kfJMU4wwUPWB8Ak5tZAj52EMAcAq6Q9Zj1MrEaQss8uH6s6eyuq16huV9Fk-v35pSK_iT7SLCuqdFXU1Sk7ytMy0NluB-zldvw8uo-nT3eT0c00zoRWJhY5eOmJUs0VeY6AaHOhQGo-U4QWiPIcpbeQavBGG229JNJecYHagBiwq-3vsqnfWwortyhCRmWZVlS3wRlAZdEmHYy3MGvqEBrK3bIpFmmzcQjuN4rrori_KJ2_2B23fkGzvd5V6IDegnVR0ub_Nzd-mOyvfwAK0Gsl</recordid><startdate>200401</startdate><enddate>200401</enddate><creator>Galle, Pia</creator><creator>Hougs, Lotte</creator><creator>Barington, Torben</creator><creator>Svenson, Morten</creator><creator>Svejgaard, Arne</creator><creator>Thomsen, Allan R.</creator><creator>Bendtzen, Klaus</creator><creator>Hansen, Morten B.</creator><general>WILEY‐VCH Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200401</creationdate><title>Knocking out IL‐6 by vaccination</title><author>Galle, Pia ; Hougs, Lotte ; Barington, Torben ; Svenson, Morten ; Svejgaard, Arne ; Thomsen, Allan R. ; Bendtzen, Klaus ; Hansen, Morten B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3768-3f0b5beea726eb210119f360572d6e190eeff15b90a70b87879b5ee7b62317803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies - immunology</topic><topic>Autoimmunity</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Interleukin-6 - analogs &amp; derivatives</topic><topic>Interleukin-6 - immunology</topic><topic>Interleukin‐6</topic><topic>Mice</topic><topic>Molecular Sequence Data</topic><topic>Protein Structure, Tertiary</topic><topic>Tolerance</topic><topic>Vaccination</topic><topic>Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galle, Pia</creatorcontrib><creatorcontrib>Hougs, Lotte</creatorcontrib><creatorcontrib>Barington, Torben</creatorcontrib><creatorcontrib>Svenson, Morten</creatorcontrib><creatorcontrib>Svejgaard, Arne</creatorcontrib><creatorcontrib>Thomsen, Allan R.</creatorcontrib><creatorcontrib>Bendtzen, Klaus</creatorcontrib><creatorcontrib>Hansen, Morten B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galle, Pia</au><au>Hougs, Lotte</au><au>Barington, Torben</au><au>Svenson, Morten</au><au>Svejgaard, Arne</au><au>Thomsen, Allan R.</au><au>Bendtzen, Klaus</au><au>Hansen, Morten B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Knocking out IL‐6 by vaccination</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2004-01</date><risdate>2004</risdate><volume>34</volume><issue>1</issue><spage>291</spage><epage>300</epage><pages>291-300</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>Inappropriate expression of IL‐6 plays a role in various inflammatory conditions, degenerative diseases, and cancers. Several model systems have been developed that can specifically block IL‐6‐receptor interactions. Here we present a simple and highly effective approach based on vaccination with a pool of specifically mutated IL‐6 analogues to induce a neutralizing IL‐6 antibody responsein mice. Judged by the ability of the analogues to bind to heterologous anti‐IL‐6 antibodies and cellular IL‐6 receptors the IL‐6 analogues seemed to have a three‐dimensional structure comparable to that of wild‐type IL‐6. Injection of them broke self‐tolerance and induced an immune response to IL‐6, presumably because of the amino acid differences between the analogues and wild‐type IL‐6. This resulted in a long‐lasting anti‐IL‐6 antibody‐mediated IL‐6 deficiency that blocked experimentally induced IL‐6‐mediated pathology.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag</pub><pmid>14971055</pmid><doi>10.1002/eji.200324338</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 2004-01, Vol.34 (1), p.291-300
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_80169194
source Wiley-Blackwell Read & Publish Collection
subjects Amino Acid Sequence
Animals
Antibodies - immunology
Autoimmunity
Female
Humans
Inflammation
Interleukin-6 - analogs & derivatives
Interleukin-6 - immunology
Interleukin‐6
Mice
Molecular Sequence Data
Protein Structure, Tertiary
Tolerance
Vaccination
Vaccines - immunology
title Knocking out IL‐6 by vaccination
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A14%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Knocking%20out%20IL%E2%80%906%20by%20vaccination&rft.jtitle=European%20journal%20of%20immunology&rft.au=Galle,%20Pia&rft.date=2004-01&rft.volume=34&rft.issue=1&rft.spage=291&rft.epage=300&rft.pages=291-300&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/eji.200324338&rft_dat=%3Cproquest_cross%3E80169194%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3768-3f0b5beea726eb210119f360572d6e190eeff15b90a70b87879b5ee7b62317803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80169194&rft_id=info:pmid/14971055&rfr_iscdi=true